Eagle Asset Management Inc. Buys 2,237 Shares of Integra Lifesciences Holdings Corp (IART)

Eagle Asset Management Inc. grew its stake in Integra Lifesciences Holdings Corp (NASDAQ:IART) by 1.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 163,096 shares of the life sciences company’s stock after purchasing an additional 2,237 shares during the period. Eagle Asset Management Inc.’s holdings in Integra Lifesciences were worth $7,892,000 at the end of the most recent reporting period.

Several other large investors also recently added to or reduced their stakes in the company. State Street Corp increased its holdings in shares of Integra Lifesciences by 5.2% in the second quarter. State Street Corp now owns 1,575,125 shares of the life sciences company’s stock valued at $85,860,000 after purchasing an additional 78,082 shares during the period. Orbimed Advisors LLC increased its holdings in shares of Integra Lifesciences by 155.5% in the third quarter. Orbimed Advisors LLC now owns 1,090,910 shares of the life sciences company’s stock valued at $55,069,000 after purchasing an additional 664,000 shares during the period. Jennison Associates LLC increased its holdings in shares of Integra Lifesciences by 48.3% in the third quarter. Jennison Associates LLC now owns 1,034,702 shares of the life sciences company’s stock valued at $52,232,000 after purchasing an additional 336,930 shares during the period. Wells Fargo & Company MN increased its holdings in shares of Integra Lifesciences by 7.8% in the fourth quarter. Wells Fargo & Company MN now owns 869,537 shares of the life sciences company’s stock valued at $41,616,000 after purchasing an additional 63,204 shares during the period. Finally, Westfield Capital Management Co. LP increased its holdings in shares of Integra Lifesciences by 5.8% in the third quarter. Westfield Capital Management Co. LP now owns 840,556 shares of the life sciences company’s stock valued at $42,431,000 after purchasing an additional 45,840 shares during the period. 86.39% of the stock is currently owned by institutional investors and hedge funds.

A number of research analysts have recently issued reports on the company. BidaskClub raised Integra Lifesciences from a “strong sell” rating to a “sell” rating in a report on Monday, February 5th. Oppenheimer reissued a “buy” rating on shares of Integra Lifesciences in a report on Thursday, October 26th. Zacks Investment Research lowered Integra Lifesciences from a “buy” rating to a “hold” rating in a report on Wednesday, October 25th. Barclays reissued a “hold” rating and issued a $53.00 target price on shares of Integra Lifesciences in a report on Tuesday, January 9th. Finally, TheStreet raised Integra Lifesciences from a “c+” rating to a “b-” rating in a report on Wednesday, February 7th. One investment analyst has rated the stock with a sell rating, ten have assigned a hold rating and three have assigned a buy rating to the company. Integra Lifesciences has an average rating of “Hold” and an average price target of $52.70.

Integra Lifesciences Holdings Corp (NASDAQ:IART) opened at $52.17 on Thursday. Integra Lifesciences Holdings Corp has a twelve month low of $40.51 and a twelve month high of $56.42. The firm has a market capitalization of $4,051.79, a price-to-earnings ratio of 28.52, a P/E/G ratio of 1.65 and a beta of 0.67. The company has a current ratio of 4.49, a quick ratio of 3.39 and a debt-to-equity ratio of 1.26.

WARNING: “Eagle Asset Management Inc. Buys 2,237 Shares of Integra Lifesciences Holdings Corp (IART)” was first reported by The Lincolnian Online and is the property of of The Lincolnian Online. If you are accessing this piece on another site, it was stolen and reposted in violation of U.S. and international copyright and trademark law. The original version of this piece can be read at https://www.thelincolnianonline.com/2018/02/22/eagle-asset-management-inc-buys-2237-shares-of-integra-lifesciences-holdings-corp-iart.html.

About Integra Lifesciences

Integra LifeSciences Holdings Corporation is a medical technology company. The Company focuses on the development, manufacturing, and marketing of surgical implants and medical instruments. Its segments include Specialty Surgical Solutions, which offers specialty surgical instrumentation for a range of specialties, including product portfolio used in the neurosurgery operating suite and critical care unit, and Orthopedics and Tissue Technologies, which includes differentiated soft tissue repair and tissue regeneration products, and small bone fixation and joint replacement solutions.

Want to see what other hedge funds are holding IART? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Integra Lifesciences Holdings Corp (NASDAQ:IART).

Institutional Ownership by Quarter for Integra Lifesciences (NASDAQ:IART)

Receive News & Ratings for Integra Lifesciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integra Lifesciences and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply